Interestingly, FAK inhibition sensitizes tumour cells to chemotherapy by suppressing NF-kB activation and subsequent cytokine production (IL-1α, IL-2, IL-4, IL-6, IL-16...) (Figure 4B) [217]. This evidence concerns the gene NFKB1 and neoplasm.